ClearPoint Neuro, Inc.
ClearPoint Neuro, Inc. (CLPT) Revenue
Annual & quarterly revenue history · segment & region breakdown
CLPT · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsClearPoint Neuro, Inc. trailing twelve-month (TTM) revenue is $0.04B, an increase of 17.78% year-over-year from $0.04B in FY2025.
Revenue trend
2025 – 2010 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $0.04B | +$0.01B | +17.78% |
| 2024-12-31 | $0.03B | +$0.01B | +31.04% |
| 2023-12-31 | $0.02B | +$0.00B | +16.56% |
| 2022-12-31 | $0.02B | +$0.00B | +26.09% |
| 2021-12-31 | $0.02B | +$0.00B | +27.05% |
| 2020-12-31 | $0.01B | +$0.00B | +14.37% |
| 2019-12-31 | $0.01B | +$0.00B | +52.54% |
| 2018-12-31 | $0.01B | -$0.00B | -0.36% |
| 2017-12-31 | $0.01B | +$0.00B | +28.35% |
| 2016-12-31 | $0.01B | +$0.00B | +25.15% |
Compare revenue vs peers
Medical - DevicesCompare CLPT revenue against listed peers. Click any row to open that company's revenue tab.
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income ClearPoint Neuro, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
ClearPoint Neuro, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from ClearPoint Neuro, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
CLPT revenue · 4 questionsCLPT's trailing twelve-month (TTM) revenue is $0.04B. That is an increase of 17.78% year-over-year from $0.04B in FY2025.
▸ Source: FMP · ClearPoint Neuro, Inc. SEC filings · GAAP · ClearPoint Neuro, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026